Overview

Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck

Status:
Completed

Trial end date:
2018-07-26

Target enrollment:

Participant gender:

Summary

This trial examines survival and toxicity in previously irradiated patients with squamous cell carcinoma of the head and neck (SCCHN) treated with radiosurgery and cetuximab and to evaluate the acute and late toxicities associated with the above therapy.

Phase:

Phase 2

Details

Lead Sponsor:

David A. Clump, MD, PhD

Treatments:

Cetuximab